These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 10792204)
1. Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy. Larsen J; Vaccheri A; Andersen M; Montanaro N; Bergman U Br J Clin Pharmacol; 2000 May; 49(5):463-71. PubMed ID: 10792204 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic prescribing in general practice: striking differences between Italy (Ravenna) and Denmark (Funen). Vaccheri A; Bjerrum L; Resi D; Bergman U; Montanaro N J Antimicrob Chemother; 2002 Dec; 50(6):989-97. PubMed ID: 12461022 [TBL] [Abstract][Full Text] [Related]
3. Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population. Larsen J; Andersen M; Kragstrup J; Gram LF Eur J Clin Pharmacol; 2001 Jul; 57(4):343-8. PubMed ID: 11549214 [TBL] [Abstract][Full Text] [Related]
4. High persistence of statin use in a Danish population: compliance study 1993-1998. Larsen J; Andersen M; Kragstrup J; Gram LF Br J Clin Pharmacol; 2002 Apr; 53(4):375-8. PubMed ID: 11966668 [TBL] [Abstract][Full Text] [Related]
5. Guidelines accompanied by changes in reimbursement rules. Effects on lipid-lowering drug prescribing. Bjerrum L; Larsen J; Kragstrup J Scand J Prim Health Care; 2001 Sep; 19(3):158-62. PubMed ID: 11697556 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic prescribing in paediatric populations: a comparison between Viareggio, Italy and Funen, Denmark. Lusini G; Lapi F; Sara B; Vannacci A; Mugelli A; Kragstrup J; Bjerrum L Eur J Public Health; 2009 Aug; 19(4):434-8. PubMed ID: 19349289 [TBL] [Abstract][Full Text] [Related]
7. Marked differences in lipid-lowering drug use in Bologna, Italy and Funen, Denmark. Bergman U; Anderssen M; Vaccheri A; Larsen J; Montanaro N Eur Heart J; 1999 Aug; 20(15):1135. PubMed ID: 10507909 [No Abstract] [Full Text] [Related]
8. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data. Gaist D Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730 [TBL] [Abstract][Full Text] [Related]
9. Deviations from evidence-based prescribing of non-steroidal anti-inflammatory drugs in three European regions. Bergman U; Andersen M; Vaccheri A; Bjerrum L; Wettermark B; Montanaro N Eur J Clin Pharmacol; 2000 Jun; 56(3):269-72. PubMed ID: 10952484 [TBL] [Abstract][Full Text] [Related]
10. Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden. Magrini N; Einarson T; Vaccheri A; McManus P; Montanaro N; Bergman U Eur J Clin Pharmacol; 1997; 53(3-4):185-9. PubMed ID: 9476029 [TBL] [Abstract][Full Text] [Related]
11. Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics. Yang CC; Jick SS; Testa MA Br J Clin Pharmacol; 2003 Jul; 56(1):84-91. PubMed ID: 12848779 [TBL] [Abstract][Full Text] [Related]
12. Prescription patterns of lipid lowering agents among older patients in general practice: an analysis from a national database in the Netherlands. Kleipool EEF; Nielen MMJ; Korevaar JC; Harskamp RE; Smulders YM; Serné E; Thijs A; Peters MJL; Muller M Age Ageing; 2019 Jul; 48(4):577-582. PubMed ID: 31074492 [TBL] [Abstract][Full Text] [Related]
13. Underuse of lipid-lowering drugs and factors associated with poor adherence: a real practice analysis in Italy. Di Martino M; Degli Esposti L; Ruffo P; Bustacchini S; Catte A; Sturani A; Degli Esposti E Eur J Clin Pharmacol; 2005 May; 61(3):225-30. PubMed ID: 15824910 [TBL] [Abstract][Full Text] [Related]
14. Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001. Hartz I; Eggen AE; Grimsgaard S; Skjold F; Njølstad I Eur J Clin Pharmacol; 2004 Nov; 60(9):643-9. PubMed ID: 15455181 [TBL] [Abstract][Full Text] [Related]
15. Use of lipid-lowering drugs during 1991-98 in Northern Jutland, Denmark. Riahi S; Fonager K; Toft E; Hvilsted-Rasmussen L; Bendsen J; Paaske Johnsen S; Sørensen HT Br J Clin Pharmacol; 2001 Sep; 52(3):307-11. PubMed ID: 11560563 [TBL] [Abstract][Full Text] [Related]
16. Marked differences in lipid-lowering drug use in bologna, italy and funen, denmark. Bergman U; Anderssen M; Vaccheri A; Larsen J; Montanaro N Eur Heart J; 1999 Aug; 20(15):1135. PubMed ID: 10413795 [No Abstract] [Full Text] [Related]
17. Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey. Salvato C; Aretini G; Serraglia D; Terrazzani G; Debetto P; Giusti P; Chinellato A Pharmacol Res; 2003 Jul; 48(1):75-82. PubMed ID: 12770518 [TBL] [Abstract][Full Text] [Related]
18. Recent trends in the consumption of lipid-lowering drugs in Finland. Martikainen J; Klaukka T; Reunanen A; Peura S; Wahlroos H J Clin Epidemiol; 1996 Dec; 49(12):1453-57. PubMed ID: 8970497 [TBL] [Abstract][Full Text] [Related]
19. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. Majumdar SR; Gurwitz JH; Soumerai SB J Gen Intern Med; 1999 Dec; 14(12):711-7. PubMed ID: 10632815 [TBL] [Abstract][Full Text] [Related]
20. [Increased use of lipid-lowering agents after implementation of clinical guidelines in general practice]. Bjerrum L; Larsen J; Kragstrup J Ugeskr Laeger; 2003 Jan; 165(2):120-3. PubMed ID: 12553092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]